The physiology of bilirubin: health and disease equilibrium

L Vitek, TD Hinds, DE Stec, C Tiribelli - Trends in molecular medicine, 2023 - cell.com
Bilirubin has several physiological functions, both beneficial and harmful. In addition to
reactive oxygen species-scavenging activities, bilirubin has potent immunosuppressive …

Induction of mild hyperbilirubinemia: hype or real therapeutic opportunity?

L Vitek, C Bellarosa, C Tiribelli - Clinical Pharmacology & …, 2019 - Wiley Online Library
Observational epidemiological studies showed that mild hyperbilirubinemia has beneficial
effects on the prevention of cardiovascular disease, type 2 diabetes mellitus, and metabolic …

Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia

MS Kostapanos, HJ Milionis, MS Elisaf - American journal of …, 2010 - Springer
HMG-CoA reductase inhibitors (statins) are the mainstay in the pharmacologic management
of dyslipidemia. Since they are widely prescribed, their safety remains an issue of concern …

[HTML][HTML] Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver

TT Li, JX An, JY Xu, BG Tuo - World Journal of Clinical Cases, 2019 - ncbi.nlm.nih.gov
Organic anion transporters (OATs) and organic anion transporter polypeptides (OATPs) are
classified within two SLC superfamilies, namely, the SLC22A superfamily and the SLCO …

Gilbert´ s syndrome revisited

L Vítek, C Tiribelli - Journal of Hepatology, 2023 - Elsevier
Gilbert´ s syndrome, also known as benign hyperbilirubinemia, was described more than
100 years ago. It has usually been considered a physiological abnormality characterized by …

Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic …

M Murray, F Zhou - British journal of pharmacology, 2017 - Wiley Online Library
Organic anion transporters (OATs) and organic anion‐transporting polypeptides (OATPs),
encoded by a number of solute carrier (SLC) 22A and SLC organic anion (SLCO) genes …

Transcriptional regulation of solute carrier drug transporters

S Zhou, Y Shu - Drug Metabolism and Disposition, 2022 - ASPET
Facilitated transport is necessitated for large size, charged, and/or hydrophilic drugs to move
across the membrane. The drug transporters in the solute carrier (SLC) superfamily, mainly …

[HTML][HTML] Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study

T Ruutu, E Juvonen, M Remberger, K Remes… - Biology of Blood and …, 2014 - Elsevier
We report the long-term results of a prospective randomized study on the use of
ursodeoxycholic acid (UDCA) for prevention of hepatic complications after allogeneic stem …

Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

HA Barton, Y Lai, TC Goosen, HM Jones… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Membrane transporters have been recognized to play a key role in determining
the absorption, distribution and elimination processes of drugs. The organic anion …

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

M Hu, B Tomlinson - Expert opinion on drug metabolism & …, 2014 - Taylor & Francis
Introduction: Statins are the cornerstone of lipid-lowering therapy to reduce the risk of
coronary heart disease. Rosuvastatin and pitavastatin are the two recently developed statins …